Targeted Therapies Are Impacting the Treatment of NETs

Nicole Ross, MSN, CRNP, AOCNP, nurse practitioner for the department of hematology/oncology​ at Fox Chase Cancer Center, discusses how targeted therapies are impacting the treatment of NETs.

In a Pharmacy Times® interview, Nicole Ross, MSN, CRNP, AOCNP, nurse practitioner for the department of hematology/oncology​ at Fox Chase Cancer Center, about her presentation on neuroendocrine tumor (NETs) management in large cancer centers at the NANETS 2021 Conference.

She discussed how targeted therapies are impacting the treatment of NETs.

Related Content:

InterviewsConference
How Pharmacists Can Positively Impact the Industry
What to Focus on When Speaking with Elected Officials in the Community
Advice for Pharmacists to Get Involved in Trade Associations, Working with Legislators